• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microb Biotechnol . Development of Dual 'RT-LAMP-LFA' Rapid Detection Technology With Gold Magnetic Nanoparticles for Influenza Virus

tetano

Editor, Senior Moderator
Microb Biotechnol


. 2025 Jun;18(6):e70169.
doi: 10.1111/1751-7915.70169. Development of Dual 'RT-LAMP-LFA' Rapid Detection Technology With Gold Magnetic Nanoparticles for Influenza Virus

Haiyang Fan[SUP] 1 [/SUP], Yonglong Gong[SUP] 1 [/SUP], Mengying Chang[SUP] 1 [/SUP], Juan Gao[SUP] 2 [/SUP], Mengjia Li[SUP] 1 [/SUP], Siyu Chen[SUP] 1 [/SUP], Ruoyi Yang[SUP] 1 [/SUP], Muxue Zhao[SUP] 1 [/SUP], Yali Cui[SUP] 1 [/SUP], Wenli Hui[SUP] 1 [/SUP]



Affiliations
Abstract

Seasonal and persistent outbreaks of influenza viruses represent a significant challenge to global public health. Rapid, convenient and accurate diagnosis methods of influenza viruses are crucial for timely treatment to mitigate morbidity and mortality during both seasonal epidemics and pandemics. However, current diagnostic tools often face limitations in speed, accuracy or complexity of result interpretation; there is a great need for more efficient detection technology for influenza virus, especially for use in resource-limited settings or during large-scale outbreaks. This study developed a dual 'RT-LAMP-LFA' detection technology with gold magnetic nanoparticles for influenza virus. This method can simultaneously detect influenza A and B genes as well as internal reference genes within 35 min, with a detection limit of 80 copies/mL. This is the first time the RNase P gene has been introduced into a gold magnetic nanoparticle lateral flow assay system as a quality control measure to monitor the entire sampling and amplification process in virus detection and reveals the effects of loop primer deficiencies on the stability of the dual 'RT-LAMP-LFA' detection technology. Using fluorescent PCR detection technology as a benchmark, the analysis of a total of 70 clinical samples demonstrated a 100% agreement rate, confirming the applicability and accuracy of the dual 'RT-LAMP-LFA' detection system. This dual 'RT-LAMP-LFA' detection technology offers a novel option for diagnostic technology in hierarchical medical testing, presenting significant social importance and broad application prospects.

Keywords: dual loop‐mediated isothermal amplification; gold magnetic nanoparticles; influenza virus; lateral flow assay.

 
Back
Top